ASTRAZENECA
AstraZeneca is an innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines that make a meaningful difference in healthcare. AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines that are innovative, effective, and which offer added benefits such as reduced side effects or better ways of taking the treatment. AstraZeneca focuses on getting the best from every medicine they make by exploring all the ways it can be used or improved. AstraZeneca was established on April 6, 1999, in Cambridgeshire, United Kingdom.
ASTRAZENECA
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical Precision Medicine
Founded:
1999-04-06
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.astrazeneca.com
Total Employee:
10001+
Status:
Active
Contact:
+44 20 3749 5000
Total Funding:
5.27 B USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Font API Google Maps Content Delivery Network LetsEncrypt Amazon
Similar Organizations
AbbVie
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
Bristol Myers Squibb
Bristol Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals.
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Novartis
Novartis is a healthcare company that provides solutions to address the evolving needs of patients worldwide.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Pfizer
Pfizer provides access to safe and effective and affordable medicines and health care services.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Roche
Roche is a pharmaceutical and diagnostics company that focuses on improving people’s lives.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2024-03-19 | Fusion Pharmaceuticals | Fusion Pharmaceuticals acquired by AstraZeneca | 2.4 B USD |
| 2024-03-14 | Amolyt Pharma | Amolyt Pharma acquired by AstraZeneca | 1.05 B USD |
| 2024-02-22 | Gracell Biotechnologies | Gracell Biotechnologies acquired by AstraZeneca | N/A |
| 2023-12-12 | Icosavax | Icosavax acquired by AstraZeneca | 1.1 B USD |
| 2023-01-09 | CinCor Pharma | CinCor Pharma acquired by AstraZeneca | 1.8 B USD |
| 2022-11-02 | Neogene Therapeutics | Neogene Therapeutics acquired by AstraZeneca | 320 M USD |
| 2022-07-05 | TeneoTwo | TeneoTwo acquired by AstraZeneca | 100 M USD |
| 2021-09-29 | Caelum Biosciences | Caelum Biosciences acquired by AstraZeneca | 500 M USD |
| 2020-12-12 | Alexion Pharmaceuticals | Alexion Pharmaceuticals acquired by AstraZeneca | 39 B USD |
| 2016-04-16 | Takeda Respiratory Business | Takeda Respiratory Business acquired by AstraZeneca | 575 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-07-16 | Huma | AstraZeneca investment in Series D - Huma | 80 M USD |
| 2024-07-08 | SmartCella | AstraZeneca investment in Private Equity Round - SmartCella | 50 M EUR |
| 2024-06-05 | Nucleus RadioPharma | AstraZeneca investment in Series A - Nucleus RadioPharma | N/A |
| 2024-05-22 | SixPeaks Bio | AstraZeneca investment in Series A - SixPeaks Bio | 30 M USD |
| 2024-05-22 | SixPeaks Bio | AstraZeneca investment in Debt Financing - SixPeaks Bio | 80 M USD |
| 2024-04-16 | Asher Bio | AstraZeneca investment in Series C - Asher Bio | 55 M USD |
| 2023-11-01 | Cellectis | AstraZeneca investment in Post-IPO Equity - Cellectis | 140 M USD |
| 2022-12-08 | GenAssist Therapeutics | AstraZeneca investment in Series A - GenAssist Therapeutics | N/A |
| 2022-11-29 | Rgenta Therapeutics | AstraZeneca investment in Series A - Rgenta Therapeutics | 52 M USD |
| 2022-11-28 | ZSHK Laboratories | AstraZeneca investment in Series B - ZSHK Laboratories | 90 M CNY |
Newest Events participated
Participated in Nordic life science Days 2017
on 2017-09-12 as sponsor
Participated in impact'17
on 2017-05-31 as sponsor
Key Employee Changes
Official Site Inspections
http://www.astrazeneca.com Semrush global rank: 74.56 K Semrush visits lastest month: 758.6 K
- Host name: ac9efcde36061855b.awsglobalaccelerator.com
- IP address: 15.197.255.153
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AstraZeneca"
AstraZeneca - Research-Based BioPharmaceutical Company
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.See details»
Leadership - Our Company - AstraZeneca
AstraZeneca - Wikipedia
AstraZeneca's reputation in China was tarnished following the failure of its Chinese subsidiary to timely donate to relief efforts following the 2008 Sichuan earthquake. Typically, donations for disaster relief in China are made through funds established through the Chinese Ministry of Civil Affairs and its subordinate organization the Red Cross Society of China. AstraZeneca had a corporate rul…See details»
AstraZeneca Canada
Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product …See details»
AstraZeneca - The Org
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.See details»
About us - AstraZeneca
We are a global, science-led, patient-focused pharmaceutical company committed to excellence in the research, development and commercialisation of prescription medicines.See details»
AstraZeneca | Pharmaceuticals, Vaccines, & Facts | Britannica
Nov 19, 2024 AstraZeneca, British-Swedish biopharmaceutical company with medicine sales in more than 130 countries, making it one of the largest drug companies in the world.See details»
Org Chart AstraZeneca - The Official Board
The organizational chart of AstraZeneca displays its 416 main executives including Pascal Soriot, Aradhana Sarin, Marc Dunoyer and Helen MacPhee. Toggle navigation The Official Board. Search. Search. Search by segment. …See details»
AstraZeneca - Crunchbase Company Profile & Funding
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines that make a meaningful difference in …See details»
Requesting Support − Sponsorships, Grants & Donations
AstraZeneca is committed to making a positive impact for people, society and the planet, including by providing grants, sponsorships, community investments and donations to organizations …See details»
AstraZeneca announces organisational changes
Jan 7, 2019 AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the …See details»
Values and Behaviours - AstraZeneca
Our values guide how we work together and are integral in defining who we are as a business and team. They lead our decision making, detail our beliefs and foster our unique culture. Our …See details»
AstraZeneca US
Oct 7, 2024 AstraZeneca awards $3.5M for projects to improve access to healthcare for patients across the US. 20 November 2024. Datopotamab deruxtecan new BLA submitted for …See details»
AstraZeneca | World Economic Forum
Feb 28, 2023 AstraZeneca is a global, science-led biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative medicines and improving …See details»
AstraZeneca Open Innovation | Innovation through collaboration
At AstraZeneca, we know that to address all the issues facing healthcare and achieve the scientific breakthroughs we aspire to, collaboration is essential.See details»
AstraZeneca | Company Overview & News - Forbes
AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: …See details»
A sustainable future starts with health - AstraZeneca
Feb 13, 2024 CEO of Seed Global Health and World Health Organization special envoy for climate and health, at a roundtable co-hosted by AstraZeneca and Seed Global Health Michel …See details»
A timeline of our company history | AstraZeneca
Astra AB is founded in Södertälje, Sweden by a group of doctors and apothecaries. Since 1913, we have continued to discover and develop innovative medicines for patients around the …See details»
Director, Resourcing and Planning at AstraZeneca
Nov 19, 2024 Participate in development opportunities internal and external to the organization that would supply to the business needs. Essential Skills/Experience: Bachelor’s Degree or …See details»
AstraZeneca's COVID-19 vaccine and seniors: Where Canada and …
Mar 3, 2021 The World Health Organization (WHO) approved the AstraZeneca-Oxford vaccine for emergency use on Feb. 15, meaning it could be rolled out globally through the global …See details»